Literature DB >> 18199480

Allostatic load in bipolar disorder: implications for pathophysiology and treatment.

Flavio Kapczinski1, Eduard Vieta, Ana Cristina Andreazza, Benicio N Frey, Fabiano A Gomes, Juliana Tramontina, Marcia Kauer-Sant'anna, Rodrigo Grassi-Oliveira, Robert M Post.   

Abstract

Current literature on the effects of chronic stress in general health converges to the concept of allostatic load (AL). AL is the bodily 'wear and tear' that emerges with sustained allostatic states. In the field of bipolar disorder (BD), AL offers an important clue as to why patients who undergo recurrent mood episodes are clinically perceived as less resilient. In addition, AL helps explaining the cumulative disruptive health effects of intermittent episodes and stressors. Stress- and episode-induced changes in brain regions involved in the emotional circuitry may lead to dysfunctional processing of information, which would render BD patients more vulnerable to subsequent environmental stressors, episodes, and drugs of abuse. Mood stabilizing agents exert opposite effects than chronic stress in neurons, increasing neuroprotective factors what may help to quench the cycle of affective episode recurrence and neural and bodily deterioration. Therefore, AL provides an explanatory link to apparently unrelated findings such as cognitive impairment and higher rates of physical comorbidity and mortality that are observed in the course of BD and further highlight the importance of effective long-term prophylaxis.

Entities:  

Mesh:

Year:  2007        PMID: 18199480     DOI: 10.1016/j.neubiorev.2007.10.005

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  95 in total

Review 1.  Staging bipolar disorder.

Authors:  Eduard Vieta; M Reinares; A R Rosa
Journal:  Neurotox Res       Date:  2010-05-12       Impact factor: 3.911

Review 2.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

3.  Intersection of Stress, Social Disadvantage, and Life Course Processes: Reframing Trauma and Mental Health.

Authors:  Paula S Nurius; Edwina Uehara; Douglas F Zatzick
Journal:  Am J Psychiatr Rehabil       Date:  2013-04

Review 4.  Stage managing bipolar disorder.

Authors:  Michael Berk; Lesley Berk; Seetal Dodd; Sue Cotton; Craig Macneil; Rothanthi Daglas; Philippe Conus; Andreas Bechdolf; Steven Moylan; Gin S Malhi
Journal:  Bipolar Disord       Date:  2013-06-20       Impact factor: 6.744

5.  Changes in the corpus callosum in women with late-stage bipolar disorder.

Authors:  L Lavagnino; B Cao; B Mwangi; M-J Wu; M Sanches; G B Zunta-Soares; F Kapczinski; J Soares
Journal:  Acta Psychiatr Scand       Date:  2015-01-31       Impact factor: 6.392

6.  Immune system dysregulation in adolescent major depressive disorder.

Authors:  Vilma Gabbay; Rachel G Klein; Carmen M Alonso; James S Babb; Melissa Nishawala; Georgette De Jesus; Glenn S Hirsch; Pauline M Z Hottinger-Blanc; Charles J Gonzalez
Journal:  J Affect Disord       Date:  2008-09-13       Impact factor: 4.839

7.  Differential abnormalities of functional connectivity of the amygdala and hippocampus in unipolar and bipolar affective disorders.

Authors:  Brenda E Benson; Mark W Willis; Terence A Ketter; Andrew Speer; Tim A Kimbrell; Peter Herscovitch; Mark S George; Robert M Post
Journal:  J Affect Disord       Date:  2014-06-02       Impact factor: 4.839

Review 8.  Toward a comprehensive clinical staging model for bipolar disorder: integrating the evidence.

Authors:  Anne Duffy
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

Review 9.  A critical update on psychological interventions for bipolar disorders.

Authors:  Eduard Vieta; Isabella Pacchiarotti; Marc Valentí; Lesley Berk; Michael Berk; Jan Scott; Francesc Colom
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

10.  The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia.

Authors:  Gabriel Selva-Vera; Vicent Balanzá-Martínez; José Salazar-Fraile; José Sánchez-Moreno; Anabel Martinez-Aran; Patricia Correa; Eduard Vieta; Rafael Tabarés-Seisdedos
Journal:  BMC Psychiatry       Date:  2010-06-15       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.